Jump to Content
Sign in
FEATURED ARTICLES
Selected Studies
Key Research
POLICY & ADVOCACY
Current Initiatives
Public Policy
EDUCATION
Meetings & Events
Distance Learning
PARTNERSHIPS
KHI
KidneyX
KIDNEY NEWS
All Issues
PDF Archive
Detective Nephron
Fellows First
Special Sections
MORE
About
Submissions
Advanced Search
Help
Sign in
FEATURED ARTICLES
Selected Studies
Key Research
POLICY & ADVOCACY
Current Initiatives
Public Policy
EDUCATION
Meetings & Events
Distance Learning
PARTNERSHIPS
KHI
KidneyX
KIDNEY NEWS
All Issues
PDF Archive
Detective Nephron
Fellows First
Special Sections
MORE
About
Submissions
SEARCH
Advanced Search
Help
Volume/Issue:
Volume 11: Issue 6
Page:
6–7
Publication Date:
01 Jun 2019
Online Publication Date:
05 Jun 2019
Headings
KN: Why build new kidneys, and why now?
KN: Please briefly describe your KidneyX 2019 award-winning entry, “Building New Kidneys.”
KN: You note that the Miromatrix products MIROMESH (soft tissue reinforcement) and MIRODERM (advanced wound care) have been implanted into thousands of patients. How does your approach to building new kidney grafts build on these products?
KN: The kidney is much more complex than these two applications. How can you be sure the kidney product will succeed?
KN: One questioner noted there are approximately 32 cell types in the kidney and asked about the certainty of their roles being preserved once they become part of 3D architecture that’s very precise. How would you respond?
KN: You stated that Miromatrix is aiming for in vivo functionality by 2020 and that the product could be in humans by 2022. Given the need for trials and regulatory approvals, are these dates realistic?
Previous Article
Next Article
Editorial Type:
Features
KidneyX Innovation Accelerator Interview 2
Volume/Issue:
Volume 11: Issue 6
Publication Date:
01 Jun 2019
Page:
6–7
Restricted access
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://www.kidneynews.org/abstract/journals/kidney-news/11/6/article-p6_4.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Share on facebook
Share on linkedin
Share on twitter
[18.97.14.84]
18.97.14.84
View Expanded
View Table
View Full Size